Uniqure

QURE NASDAQ
73.86
-0.73
-0.98%
Opening 10:43 07/19 EDT
Open
75.08
Prev Close
74.59
High
75.08
Low
73.53
Volume
157.87K
Avg Vol (3M)
706.42K
52 Week High
82.49
52 Week Low
21.98
% Turnover
0.42%
Market Cap
2.79B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Uniqure QURE stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Uniqure NV is a gene therapy company based in the Netherlands. The Company is engaged in the discovery, development and commercialization of single treatments with curative results for patients suffering from genetic and other severe diseases. The Company advances a focused pipeline of gene therapies that are developed both internally and through partnerships. The Company’s product candidates within the Core Program include AMT-061 for Hemophilia B, AMT-130 for Huntington's disease and S100A1 for congestive heart failure. The Company, through its collaboration with Bristol Myers-Squibb (BMS), is focused on building a portfolio of gene therapies led by the S100A1 program for congestive heart failure.
MORE >

Recently

Name
Price
%Change